Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109824539B details a novel 6-step Tigecycline synthesis from Demethyl Aureomycin, offering high purity, cost reduction, and scalable manufacturing for pharmaceutical intermediates.
Patent CN116396221B reveals a high-purity synthesis route for pyrazole derivatives. This report analyzes cost reduction in fungicide manufacturing and supply chain reliability for global buyers.
Novel halogenation method for Relugolix synthesis improves yield to 67.4% and purity to 99%, offering cost reduction in pharmaceutical manufacturing.
Patent CN110551033B details a novel Ir-catalyzed asymmetric reductive amination method. Achieve high enantioselectivity and cost reduction in chiral amine manufacturing with scalable processes.
Patent CN110551033B details a high-efficiency iridium-catalyzed asymmetric reductive amination method. Achieve superior enantioselectivity and cost reduction in chiral amine manufacturing for pharma and agrochemicals.
Patent CN108395408B details a scalable route for [4-(1,1-difluoro-ethyl)-pyrimidine]-5-methanamine. Achieve cost reduction in API manufacturing with this efficient aqueous reduction strategy.
Patent CN110551032A details iridium catalyzed asymmetric reductive amination. Delivers high purity chiral amines with significant supply chain and cost advantages.
Patent CN104263796A details a high-yield chiral synthesis route. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN102712593B reveals improved synthesis using hydrophilic ethers. Achieves high purity and reduced reaction time for scalable pharmaceutical intermediates manufacturing.
Patent CN113582823A details a high-yield route for 2-amino-9,9-diphenylfluorene using liquid ammonia amination, offering cost-effective OLED material manufacturing solutions.
Advanced catalytic method for high-purity 1-amino-2,3-propanediol synthesis. Reduces by-products and enhances supply chain reliability for iohexol intermediates.
Novel catalytic amination process for ethacridine reduces waste and improves purity. Ideal for pharmaceutical supply chains seeking cost-effective API manufacturing solutions.
Novel patent CN104945265B offers high-yield 2-aminoindene synthesis. Reduces costs and improves supply chain reliability for global pharma manufacturers.
Patent CN106883238B reveals a high-yield 4-step route for alpha-azaspiro compounds, offering significant cost reduction and safety improvements for API intermediate manufacturing.
Patent CN103497202A details a safer reduction method for dorzolamide intermediates, eliminating toxic boranes and improving yield for reliable supply.
Patent CN103145562A details a safe, ambient-pressure route for N-ethylaniline using acetaldehyde, offering superior purity and cost efficiency for fine chemical manufacturing.
Novel chiral synthesis route for octahydro-2H-pyrrolo[3,4-c]pyridine derivatives offering high purity and scalable pharmaceutical intermediate production capabilities.
Novel 4-step route for Elacestrant intermediate. High purity, scalable process for pharmaceutical supply chain cost reduction and efficiency.
Novel biocatalytic method for (S)-2-amino-1-butanol and (R)-3-amino-1-butanol using amine dehydrogenases. High yield, mild conditions, scalable process for pharmaceutical intermediates.
Patent CN113185478B reveals a novel ethylenediamine-based route for N-Boc-piperazine, offering superior purity and significant cost reduction for pharmaceutical manufacturing.